# HQ Pharma (Shanghai) Co., Ltd. – FDA Inspection, Nov 8, 2023

Source: https://www.keypedia.com/records/fda_inspections/hq-pharma-shanghai-co-ltd/5b19d392-ee65-46aa-8767-de5c801ba507
Source feed: FDA_Inspections

> FDA inspection 1223658 of HQ Pharma (Shanghai) Co., Ltd., November 08, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223658
- Company Name: HQ Pharma (Shanghai) Co., Ltd.
- Inspection Date: 2023-11-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kevin-p-regan/b870e1f2-017c-44ab-bc99-1ca99b474a04)

Company: https://www.keypedia.com/companies/hq-pharma-shanghai-co-ltd/52900660-38e9-45d2-b35b-829134124602

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8